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Abstract
Background: Obesity is well known as a risk factor for cardiovascular disease. We aimed to determine the
performance of and the optimal cutoff values for obesity indices to discriminate the presence of metabolic
abnormalities as a primary risk factor for cardiovascular diseases in a Health Examinees study (HEXA).
Methods: The current study analyzed 134,195 participants with complete anthropometric and laboratory
information in a Health Examinees study, consisting of the Korean population aged 40 to 69 years. The presence of
metabolic abnormality was defined as having at least one of the following: hypertension, hyperglycemia, or
dyslipidemia. The area under the receiver operating characteristic curve (AUC) and 95% confidence intervals (CIs)
were calculated for body mass index, waist to hip ratio, waist to height ratio, waist circumference, and conicity
index.
Results: The AUC of metabolic abnormalities was the highest for waist-to-height ratio (AUC [95% CIs], 0.677 [0.672–
0.683] among men; 0.691 [0.687–0.694] among women), and the lowest for the C index (0.616 [0.611–0.622] among
men; 0.645 [0.641–0.649] among women) among both men and women. The optimal cutoff values were 24.3 kg/
m2 for the body mass index, 0.887 for the waist-to-hip ratio, 0.499 for the waist-to-height ratio, 84.4 cm for waist
circumference and 1.20 m3/2/kg1/2 for the conicity index among men, and 23.4 kg/m2 for the body mass index,
0.832 for the waist-to-hip ratio, 0.496 for the waist-to-height ratio, 77.0 cm for the waist circumference and 1.18
m3/2/kg1/2 for the conicity index among women.
Conclusion: The waist-to-height ratio is the best index to discriminate metabolic abnormalities among middle-
aged Koreans. The optimal cutoff of obesity indices is lower than the international guidelines for obesity. It would
be appropriate to use the indices for abdominal obesity rather than general obesity and to consider a lower level
of body mass index and waist circumference than the current guidelines to determine obesity-related health
problems in Koreans.
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Background
Obesity has emerged as a public concern worldwide, as
its incidence has been steadily increasing [1]. The Global
Burden of Disease Study reported that the estimated
worldwide prevalence rates of obesity were 28.8 to 36.9%
in men and 29.8 to 38.0% in women between 1980 and
2013 [2], and global death attributable to obesity rapidly
increased more than doubling between 1990 and 2017
[3]. People with obesity are at increased risk for cardio-
vascular diseases, type 2 diabetes, certain cancers, and
premature death [4, 5].
Body mass index is widely used for defining general
obesity. The World Health Organization (WHO) recom-
mended a lower cutoff point of body mass index for
Asian populations than for Western populations [6], and
it reflects the realization that adverse health is associated
with a lower body mass index than the WHO criteria for
Western countries [7]. Furthermore, recent studies have
concluded that waist circumference, waist-to-hip ratio,
and waist-to-height ratio better discriminate obesity-
related metabolic abnormalities than body mass index
[8–10]. Therefore, it is necessary to identify the optimal
cutoff of obesity indices and to assess the discriminative
power for obesity-related health problems in representa-
tive Asian populations. In this study, we aimed to evalu-
ate the performance of obesity indices and to determine
the optimal cutoff values for obesity indices to discrim-
inate the presence of metabolic abnormalities in middle-
aged Koreans. We comparatively investigated five obesity
indices, including body mass index, waist circumference,
waist-to-hip ratio, waist-to-height ratio, and conicity
index, in the analyses.
Method
Study population
The Health Examinees (HEXA) study is a part of the Korea
Genome Epidemiology Study (KoGES) [11]. National
Health Insurance Corporation (NHIC) covers the entire
Korean population for general health screening, and benefi-
ciaries aged over 40 years can biannually receive screening
through the national health examination program [12]. Par-
ticipants in the HEXA study were prospectively recruited
from 2004 to 2013 at 38 health examination centers and
training hospitals located in 8 regions based on the infra-
structural advantage of the national health checkup services
funded by the Korea Centers for Disease Control and
Prevention [11].
Figure 1 shows the flow chart of the study population.
We included HEXA participants aged 40 to 69 years in
the analyses and restricted them to Health Examinees-
Gem (HEXA-G) participants who were defined as fol-
lows: we excluded (1) 8 sites (n = 9370) that only partici-
pated in the pilot study years 2004–2006, (2) 8 sites (n =
12,205) that did not meet the HEXA biospecimen
quality control criteria (i.e., different testing protocols),
and (3) 5 sites (n = 8799) that had participated in the
study for less than 2 years. A total of 139,348 partici-
pants were included in the HEXA-G data. Among
HEXA-G participants, we excluded 1391 participants
who had no information on anthropometric measure-
ments of height, weight, waist circumference, and hip
circumference. An additional 3762 participants had no
information on blood pressure or biochemical measure-
ments of the blood specimen, such as fasting glucose,
triglyceride, and high-density lipoprotein. We conducted
all analyses among the 134,195 participants who
remained after exclusion.
Data collection
Participants were interviewed by trained interviewers
and responded to a structured questionnaire on general
characteristics and past medical history. Biochemical
assessments and anthropometric measurements were
also conducted for all participants. Blood specimens
were taken after 8 h of fasting at enrollment and were
transported to the clinical laboratory for blood tests
using plasma to examine the levels of glucose, triglycer-
ide, and high-density lipoprotein. Height was measured
using digital freestanding stadiometers (BSM, InBody
Co, Seoul, Korea) with the participants’ head in the
Frankfort horizontal plane and was read up to one deci-
mal place. Weight was measured using digital scales
(BSM, InBody Co, Seoul, Korea) in units of 10 g. Waist
and hip circumferences were obtained with a measuring
tape in a horizontal plane and were read up to one deci-
mal place. In detail, waist circumference was measured
at the midpoint between the lower margin of the last
palpable rib and the top of the iliac crest, and hip cir-
cumference was measured around the widest part of the
buttocks.
Systolic and diastolic blood pressure values were
manually measured using a stethoscope and mercury
sphygmomanometer on one arm in the sitting position
according to the standard operating procedure by
trained medical staff. Blood pressure was measured at
least twice, and the second blood pressure measurement
was taken at least 1 min after the first measurement. If
the difference between the two records of blood pressure
was more than 5mmHg, additional measurements were
taken until the last two records of blood pressure were
similar. Then, the last two records of blood pressures
were recorded. Blood pressure was measured in both
arms and was remeasured if the difference in blood pres-
sure between both arms was more than 10 mmHg. Blood
pressure was measured on the other arm only if there
were arm injuries, previous breast surgery, venous or
arterial tubes, or plaster bandages. We determined blood
pressure as the average of the two readings.
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Definition of terms
Body mass index, waist circumference, waist-to-hip ratio,
and waist-to-height ratio were calculated using directly
measured anthropometric values. Additionally, we con-
sidered the conicity index as a measure of central
adiposity with the equation below [13].






Participants meeting at least one of the following
criteria were considered to have metabolic abnormalities:
defined hypertension [14], those who had systolic blood
pressure higher than 140mmHg or diastolic blood pres-
sure higher than 90 mmHg, or those who reported
taking antihypertensive medication; hyperglycemia [15],
those who had a fasting blood glucose higher than 126
mg/dL or who reported taking antidiabetic medication;
and dyslipidemia, those who had a triglyceride level
higher than 150 mg/mL, high-density lipoprotein choles-
terol lower than 40mg/dL, or those who reported taking
medication for dyslipidemia. Low-density lipoprotein
cholesterol is commonly used for diagnoses of dyslipid-
emia, but low-density lipoprotein cholesterol was not
directly measured from blood samples. Therefore, we
defined dyslipidemia using the levels of triglycerides and
high-density lipoprotein cholesterol.
Statistical analyses
We calculated the means and standard deviations for
demographic, anthropometric, blood pressure, and bio-
chemical characteristics. The inclusion of a large popula-
tion in this study would reduce the meaningfulness of
statistical significance for differences in the general
characteristics between sexes. For this reason, we did
not present a p-value in the descriptive analysis of
Tables 1 and 2. Receiver operating characteristic (ROC)
curves were plotted for obesity indices to identify the
best obesity index that discriminates the presence of
metabolic abnormalities. The area under the receiver
Fig. 1 Inclusion and exclusion criteria of the study population
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operating characteristic curves (AUCs) was used as a
summary measure of accuracy to evaluate the perform-
ance of obesity indices for the discrimination of partici-
pants with metabolic dysfunctions. Youden’s J statistics
[16] were used to determine the optimal cutoff values
for the obesity indices. Youden’s index was calculated
using the equation below.
Youden
0
J statistics ¼ sensitivityþ specificity − 1
We considered the optimal cutoff values at the corre-
sponding value for the maximum Youden index. All stat-
istical analyses were stratified by sex. We analyzed data
using SAS version 9.4 (SAS Institute Inc., Cary, NC,
USA) for the calculation of optimal cutoff points and R
software version 3.6.3 [17] for the calculation of the
AUCs.
Results
The anthropometric indices of obesity and metabolic
characteristics are presented in Table 1. The mean ages
were 53.6 years for men and 52.3 years for women. Men
had higher values than women for all anthropometric,
blood pressure, and biochemical characteristics, except
for high-density lipoprotein cholesterol. Table 2 de-
scribes the prevalence of hypertension, diabetes, hyper-
glycemia, dyslipidemia, and metabolic abnormalities
among HEXA-G participants by sex. More than half of
the participants had at least a single metabolic abnor-
mality of diabetes, hypertension, or dyslipidemia in both
men (65.7%) and women (55.7%). The prevalence of
metabolic abnormalities was higher in men than in
women. Among the components of metabolic abnormal-
ities, the prevalence was the lowest for hyperglycemia
(11.5% for men; 6.0% for women) and highest for dyslip-
idemia (48.4% for men; 44.6% for women).
The AUCs of the obesity indices associated with meta-
bolic abnormalities and their components are shown in
Table 3. Among men, the highest AUCs to discriminate
metabolic abnormalities were obtained in the waist-to-
height ratio (AUC [95% confidence intervals], 0.677
[0.672–0.683]), followed by the waist circumference
(0.671 [0.666–0.677]), body mass index (0.667 [0.661–
0.672]) and the waist-to-hip ratio (0.656 [0.650–0.661])
and conicity index (0.616 [0.611–0.622]); the AUCs of
the waist-to-hip ratio and the conicity index were signifi-
cantly lower than those of the waist-to-height ratio, the
waist circumference, and the body mass index. Among
women, the highest AUCs were obtained in the waist-
to-height ratio (0.691 [0.687–0.694]), followed by the
waist-to-hip ratio (0.681 [0.677–0.684]), the waist
Table 1 Anthropometric indices of obesity and metabolic characteristics among HEXA-G participants by sex, mean ± standard
deviation
Men (N = 45,052) Women (N = 89,143)
Age, years 53.6 ± 8.38 52.3 ± 7.76
Height, cm 168.8 ± 5.74 156.5 ± 5.26
Weight, cm 69.6 ± 9.23 57.9 ± 7.66
Waist circumference, cm 85.7 ± 7.52 78.3 ± 8.17
Hip circumference, cm 96.0 ± 5.64 93.5 ± 5.69
Body mass index, kg/m2 24.4 ± 2.75 23.6 ± 2.94
Waist-to-hip ratio 0.89 ± 0.05 0.84 ± 0.06
Waist-to-height ratio 0.51 ± 0.04 0.50 ± 0.06
Conicity index, m3/2/kg1/2 1.23 ± 0.06 1.18 ± 0.08
Systolic blood pressure, mmHg 125.7 ± 14.35 120.6 ± 15.17
Diastolic blood pressure, mmHg 78.7 ± 9.68 74.7 ± 9.66
Fasting serum glucose level, mg/dL 99.3 ± 24.28 92.7 ± 18.47
Triglyceride, mg/dL 151.4 ± 111.41 112.5 ± 74.18
High-density lipoprotein cholesterol, mg/dL 49.4 ± 12.09 56.1 ± 12.80
Table 2 Prevalence of metabolic abnormalities among HEXA-G
participants by sex
Men Women
Hypertensiona, n (%) 15,310 (34.0) 21,386 (24.0)
Hyperglycemiab, n (%) 5196 (11.5) 5319 (6.0)
Dyslipidemiac, n (%) 21,794 (48.4) 39,768 (44.6)
Metabolic abnormalitiesd, n (%) 29,605 (65.7) 49,680 (55.7)
aSystolic blood pressure higher than 140 mmHg, diastolic blood pressure
higher than 90 mmHg or those who reported taking
antihypertensive medication
bFasting glucose higher than 126 mg/dL or those who reported taking
antidiabetic medication
cTriglyceride higher than 150mg/mL, high-density lipoprotein cholesterol
lower than 40 mg/dL or those who reported taking medication
for dyslipidemia
dHaving at least one of the aforementioned factors
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circumference (0.680 [0.677–0.684]), the body mass
index (0.668 [0.665–0.672]) and the conicity index
(0.645 [0.641–0.649]). Women had higher AUCs associ-
ated with metabolic abnormalities for all obesity indices
than men.
Table 4 shows the optimal cutoff values of obesity in-
dices for metabolic abnormalities. Optimal cutoff values
to discriminate metabolic abnormalities were 24.3 kg/m2
for the body mass index, 84.4 cm for the waist circum-
ference, 0.887 for the waist-to-hip ratio, 0.499 for the
waist-to-height ratio and 1.20 m3/2/kg1/2 for the conicity
index for men and 23.4 kg/m2 for the body mass index,
77.0 cm for the waist circumference, 0.832 for the waist-
to-hip ratio, 0.496 for the waist-to-height ratio and 1.18
m3/2/kg1/2 for the conicity index for women.
Discussion
Using the baseline data from a large community-based
cohort study, we examined the discriminative perform-
ance of obesity indices for the presence of metabolic ab-
normalities by calculating the AUCs. The highest
discriminative power to discriminate metabolic abnor-
malities was shown for the waist-to-height ratio among
both men and women. Compared with body mass index,
as an index of general obesity, indices for abdominal
obesity (i.e., waist circumference, waist-to-hip ratio and
waist-to-height ratio) show better performance in dis-
criminating abnormal metabolic status. Among the indi-
ces for abdominal obesity, there was no significant
difference in the discriminative power to the presence of
metabolic abnormalities between waist circumference
and waist-to-hip ratio.
We also determined the optimal cutoff values of obes-
ity indices in the present study. The optimal cutoff of
the waist-to-height ratio for all factors of metabolic ab-
normalities was approximately 0.5 for both men and
women, which is consistent with the results from a pre-
viously published systematic review [18]. The optimal
cutoff values of the waist circumference, waist-to-hip ra-
tio and body mass index were different for each factor of
metabolic abnormalities.
Although body mass index is widely used to determine
healthy weight, abdominal obesity indices have been re-
ported to be better tools to discriminate the presence of
metabolic abnormalities in Asians [19–23], Australians
[24], and Americans [25]. A previous prospective cohort
study on the obesity index and metabolic dysfunction
also showed that abdominal obesity indices, especially
the waist-to-hip ratio, were a better predictor than body
mass index for developing multiple metabolic risk fac-
tors in the Korean population [26].
A meta-analysis from previously published cross-
sectional or cohort studies compared the AUCs of waist-
to-height ratio, waist circumference and body mass
index in discriminating obesity-related disease and con-
cluded that the waist-to-height ratio has superior per-
formance over body mass index and waist circumference
[8]. A higher discriminative power of the waist-to-height
ratio than body mass index was also presented in other
meta-analysis results based on previously conducted
prospective studies [9]. Furthermore, the waist-to-height
ratio was shown to be a significantly better tool than
waist circumference in a meta-analysis of within-study
differences in AUCs between the waist-to-height ratio
and waist circumference [8]. However, the difference in
the discriminative performance of body mass index,
waist circumference and waist-to-hip ratio has not
Table 3 Areas under the receiver operating characteristic curves
and the corresponding 95% confidence intervals of obesity
indices associated with metabolic abnormalities and their
components among HEXA-G participants by sex
Men Women
Hypertensiona
Body mass index 0.629 (0.624–0.635) 0.668 (0.664–0.672)
Waist circumference 0.629 (0.624–0.635) 0.671 (0.667–0.675)
Waist-to-hip ratio 0.617 (0.612–0.623) 0.665 (0.661–0.669)
Waist-to-height ratio 0.646 (0.640–0.651) 0.687 (0.683–0.691)
Conicity index 0.593 (0.587–0.598) 0.635 (0.631–0.639)
Hyperglycemiab
Body mass index 0.570 (0.562–0.579) 0.642 (0.634–0.649)
Waist circumference 0.605 (0.597–0.613) 0.683 (0.675–0.690)
Waist-to-hip ratio 0.636 (0.629–0.644) 0.715 (0.708–0.721)
Waist-to-height ratio 0.616 (0.608–0.624) 0.693 (0.686–0.700)
Conicity index 0.611 (0.603–0.619) 0.674 (0.667–0.681)
Dyslipidemiac
Body mass index 0.645 (0.640–0.650) 0.636 (0.632–0.639)
Waist circumference 0.645 (0.640–0.651) 0.648 (0.644–0.652)
Waist-to-hip ratio 0.625 (0.620–0.630) 0.651 (0.647–0.654)
Waist-to-height ratio 0.641 (0.636–0.646) 0.653 (0.649–0.657)
Conicity index 0.587 (0.582–0.593) 0.618 (0.614–0.622)
Metabolic abnormalitiesd
Body mass index 0.667 (0.661–0.672) 0.668 (0.665–0.672)
Waist circumference 0.671 (0.666–0.677) 0.680 (0.677–0.684)
Waist-to-hip ratio 0.656 (0.650–0.661) 0.681 (0.677–0.684)
Waist-to-height ratio 0.677 (0.672–0.683) 0.691 (0.687–0.694)
Conicity index 0.616 (0.611–0.622) 0.645 (0.641–0.649)
aSystolic blood pressure higher than 140 mmHg, diastolic blood pressure
higher than 90 mmHg or those who reported taking
antihypertensive medication
bfasting glucose higher than 126 mg/dL or those who reported taking
antidiabetic medication
ctriglyceride higher than 150 mg/mL, high-density lipoprotein cholesterol
lower than 40 mg/dL or those who reported taking medication
for dyslipidemia
dHaving at least one of the aforementioned factors
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shown statistical significance in the pooled analysis of
over eighty thousand individual data from British co-
horts [10].
The optimal cutoff values of body mass index and
waist circumference from the present study were
lower than previous guidelines of the WHO [6] and
the National Cholesterol Educational Program (NCEP)
[27]. Our results showed that body mass indices of
more than 24.3 kg/m2 among men and 23.4 kg/m2
among women were associated with the presence of
metabolic abnormalities, while the WHO
recommended that obesity in Asian populations be
defined as a body mass index of 25 kg/m2 or higher
[6]. We obtained waist circumference cutoffs of 84.4
cm for men and 77.0 cm for women, and these results
are lower than the NCEP guidelines for metabolic
syndrome, which defined obesity as a waist
circumference of more than 90 cm for men and 80
cm for women [9]. We suggested that a lower cutoff
abdominal obesity index could discriminate metabolic
dysfunction in Asians. A previous prospective cohort
study in Korea also described that lower waist circumfer-
ence (80 cm for men and 78 cm for women) had a better
performance to predict the development of metabolic
abnormalities than the NCEP guidelines [27].
This study had several limitations. First, there is an in-
herent limitation of temporality in the cross-sectional
design. However, our results are similar to the results
from prospective studies in Korea [20, 26], and we sug-
gest that the theoretical effect of the temporality of our
results is not strong. Second, it is difficult to generalize
these results to young people. The study participants
consisted of Koreans aged 40 to 60 years who regularly
attended health screening examinations; therefore, the
Table 4 Optimal cutoff values, Youden indices, and sensitivity and specificity of obesity indices associated with metabolic












Body mass index 24.5 0.189 0.596 0.593 23.5 0.246 0.670 0.576
Waist circumference 87.0 0.187 0.570 0.617 78.9 0.255 0.655 0.600
Waist-to-hip ratio 0.896 0.175 0.594 0.581 0.840 0.241 0.662 0.580
Waist-to-height ratio 0.506 0.210 0.662 0.548 0.503 0.275 0.674 0.601
Conicity index 1.24 0.138 0.535 0.604 1.19 0.199 0.607 0.592
Hyperglycemiab
Body mass index 24.5 0.104 0.567 0.537 24.2 0.207 0.569 0.637
Waist circumference 86.3 0.150 0.591 0.559 80.0 0.272 0.672 0.600
Waist-to-hip ratio 0.895 0.197 0.660 0.537 0.850 0.315 0.710 0.606
Waist-to-height ratio 0.509 0.165 0.634 0.531 0.514 0.288 0.655 0.633
Conicity index 1.23 0.165 0.655 0.510 1.18 0.255 0.728 0.527
Dyslipidemiac
Body mass index 24.0 0.213 0.654 0.559 23.2 0.198 0.634 0.564
Waist circumference 84.4 0.208 0.675 0.533 77.5 0.219 0.640 0.579
Waist-to-hip ratio 0.879 0.185 0.712 0.474 0.832 0.227 0.652 0.575
Waist-to-height ratio 0.502 0.204 0.661 0.542 0.497 0.228 0.636 0.592
Conicity index 1.20 0.131 0.706 0.425 1.18 0.175 0.608 0.567
Metabolic abnormalityd
Body mass index 24.3 0.241 0.588 0.653 23.4 0.245 0.604 0.641
Waist circumference 84.4 0.248 0.653 0.595 77.0 0.266 0.676 0.590
Waist-to-hip ratio 0.887 0.228 0.639 0.589 0.832 0.270 0.645 0.624
Waist-to-height ratio 0.499 0.259 0.672 0.587 0.496 0.281 0.638 0.644
Conicity index 1.20 0.173 0.698 0.475 1.18 0.210 0.598 0.613
aSystolic blood pressure higher than 140 mmHg, diastolic blood pressure higher than 90mmHg or those who reported taking antihypertensive medication
bFasting glucose higher than 126 mg/dL or those who reported taking antidiabetic medication
cTriglyceride higher than 150mg/mL, high-density lipoprotein cholesterol lower than 40 mg/dL or those who reported taking medication for dyslipidemia
dHaving at least one of the aforementioned factors
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cutoff values derived from the current study may be
relevant to the middle-aged Korean population only.
Conclusions
The waist-to-height ratio is the best index to discrimin-
ate metabolic abnormalities among middle-aged Ko-
reans. The optimal cutoff of obesity indices of body
mass index and waist to circumference is lower than the
recommendations from the WHO and NCEP. Based on
these findings, to determine obesity-related health prob-
lems in Koreans, it would be appropriate to use indices
for abdominal obesity rather than general obesity and to
consider a lower level of body mass index and waist cir-
cumference than the current guidelines. We hope that
these results will improve the guidelines for screening
populations at high risk for cardiometabolic diseases via
appropriate recommendations for obesity in Korea.
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